5 completed. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 2 | Completed 2 |
Follow T Cell Lymphoma: new trials by email Literature Review of T Cell Lymphoma trials Research Report on T Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies CTX131 - T Cell Lymphoma, B Cell Lymphoma | Phase 1 / Phase 2 | Completed | CRISPR Therapeutics | 12 | 2024-08-13 | 2026-04-03 |
| Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma chimeric antigen receptor T cell treatment - T Cell Lymphoma, T-cell Leukemia | Phase 1 | Completed | Beijing Boren Hospital | 16 | 2021-09-14 | 2024-11-14 |
| Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma Tenalisib, Romidepsin - T Cell Lymphoma | Phase 1 / Phase 2 | Completed | Rhizen Pharmaceuticals SA | 33 | 2019-03-12 | 2022-10-28 |
| AMG 319 Lymphoid Malignancy FIH AMG 319 - Cancer, Chronic Lymphocytic Leukemia | Phase 1 | Completed | Amgen | 28 | 2011-04-01 | 2017-02-09 |
| A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients Sorafenib - T Cell Lymphoma | Phase 1 | Completed | Yale University | 12 | 2009-10-01 | 2020-08-13 |
Lymphoma, T-Cell (5) · Leukemia (2) · Hematologic Neoplasms (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Leukemia, T-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms (1) · Recurrence (1)
Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Lymphatic Diseases (5) · Lymphoproliferative Disorders (5) · Neoplasms by Histologic Type (5) · Lymphoma (4) · Lymphoma, Non-Hodgkin (4) · Neoplasms (4) · Hematologic Diseases (3) · Disease Attributes (2) · Leukemia, Lymphoid (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Chronic Disease (1)
N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (1) · Sorafenib (1) · romidepsin (1) · tenalisib (1)
Amgen (1) · Beijing Boren Hospital (1) · CRISPR Therapeutics (1) · Rhizen Pharmaceuticals SA (1) · Yale University (1)
United States (4) · Australia (1) · China (1)
Alissa Keegan, MD, PhD (1) · Francine Foss, MD (1)